Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stefano Bini

Orthopaedic Surgery Oakland, CA Medical Doctor

NPI 1619055415 CMS profile 118869

275 W MacArthur, Oakland, CA 94611

Open in the dashboard

General payments

$3,210,720

300 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,305 paid to institutions, not to them · program year 2019

Through program year 2025, Stefano Bini of Oakland, CA is reported in the CMS Open Payments database as having received $3,210,720 across 300 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $11,305 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $763,909 85
2024 General $214,471 49
2023 General $661,743 50
2022 General $581,849 18
2021 General $547,691 24
2020 General $370,871 11
2019 General $70,186 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stefano Bini
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Stefano Bini were reported at $763,909. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Stefano Bini Orthopaedic Surgery median Middle half National median
2019 $70,186 $644 $140–$2,844 $163
2020 $370,871 $312 $75–$1,860 $114
2021 $547,691 $520 $117–$2,495 $132
2022 $581,849 $598 $128–$2,731 $149
2023 $661,743 $461 $128–$2,264 $160
2024 $214,471 $497 $134–$2,475 $164
2025 $763,909 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,409,231 174 payments
  2. Zimmer Biomet Holdings, Inc. $801,294 122 payments
  3. Conformis, Inc. $144 2 payments
  4. Vertex Pharmaceuticals Incorporated $36 1 payment
  5. Ethicon US, LLC $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,267,192 16 payments
  2. Consulting Fee $814,791 30 payments
  3. Travel and Lodging $74,371 130 payments
  4. Education $45,750 12 payments
  5. Food and Beverage $8,616 112 payments
Products named General payments · program years 2019–2025
  1. ACCOLADE Hips $1,926,335 16 payments
  2. ACCOLADE Hips $348,928 8 payments
  3. MAKO Knees, Hips $88,378 64 payments
  4. MAKO Knees, Hips $34,876 67 payments
  5. Persona $27,450 13 payments
  6. Avenir $20,750 6 payments
  7. Arcos $20,750 6 payments
  8. G7 $20,750 6 payments
  9. TRIATHLON Knees $3,050 3 payments
  10. TRIATHLON Knees $3,000 2 payments
  11. Other $7,067 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$85,631

Medicare's payments for the services billed

Medicare patients

196

Average age 73

Services billed

322

115 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Depression 26%
Diabetes 23%
Osteoporosis 23%
Ischemic heart disease 22%
Chronic kidney disease 21%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

300 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record